Member Info for x66rjp

https://www.proactiveinvestors.co.uk/companies/news/916429/saga-shelves-dividend-but-says-insurance-business-provides-coronavirus-flexibility-916429.html

The impairment was due to their expectation of performance in their insurance business so not great. Hopefully the bad news is behind them and its onwards and upwards (once the pandemic has finished).

My concern was the balance sheet is barely solvent if the goodwill figure is removed (and thats not taking into account the other intangibles). You make a good point about cash in regard to its operating activities but its cashflow has actually decreased in 2019 by £69.7m (in 2018 it was an increase of £5.5m). Although a chunk of that for 2019 is down to dividends (and we wont complain about those).

I don't see it hitting 2.30 today but agree a potential buy tomorrow.

Share price looks attractive from a growth and dividend standpoint. However, looking at the balance sheet that goodwill figure sticks out like a sore thumb (and its bigger than the market cap/value of the company). Also the impairment in 2019 is a bit worrying as is the long term deteriorating sp.
But sentiment for a business like this will probably rule. Lucky the cruise/travel business is quite small. On the fence on this one but will keep it on the watchlist.

Warwick - can you help me to understand why you are posting. This was a long message and of you're not invested why do you care? Feels like you're wasting you're evening / time?

I agree, feels like a long term one. Hopefully some good contracts have been secured and we see some upward movement on the next RNS.

Think I'll stick to coming on here in the evenings. Seems a bit more like there's sensible people. The day is a grind listening to crazy people who aren't even invested here. Going to be boom or bust...all good fun.

Fingers crossed henderz! A successful trial and an sp rise would be great.

North - I agree. Only have to look out of my window and it's a different picture to how it was a couple of weeks ago.

Nolupus - nobody thought this would be a silver bullet. It was always going to be a treatment for covid, there would always be others. It seems market sentiment for now at least is winning.

Market sentiment (for now) suggests a treatment isn't needed. Not sure what other explanation there is for this.

Agree with Saint - comes down to orders and subsequent revenue. The sentiment has gone for now for these stocks but orders and sales are substance. A CE mark is progress but not money in the bank.
When in averaged down at 1.42 I thought it had bottomed, now seems silly.

Not convinced in the next year. Think there'll be a recession and this FTSE rally will prove to be just that.

Buy or sell?

crl - spot on. This drop is still hurting though, need treatment for that.

Aware Nolupus raised a question/point regarding the timing of the copd and covid results. Would we assume if copd comes first there is the expectation covid will be positive? If copd was negative we would assume covid must be positive (albeit it is a blind trial) or the company is going to struggle?

https://www.theguardian.com/world/2020/jun/04/spain-says-british-tourists-welcome-back-once-uk-clarifies-policy

Seems a bit inconclusive. Synairgen can fill in the blanks when they get the results.

Fingers crossed!